Helpline : 9807 55 6789
Indo-British Advanced Pain Management Recognized and Awarded Pioneer in Pain Medicine, Neuromodulation, and Spinal Cord Stimulation

Neuropathic Pain: When the Nervous System Becomes the Enemy

A specialist’s honest, evidence-based guide to ozone nucleolysis — how it works, why thousands of patients across HyderabadA complete guide to nerve pain types, mechanisms, and advanced non-surgical treatments — by Dr Vijay Bhaskar Bandikatla, Consultant in Pain Medicine, Hyderabad have benefited, and what you really need to know before choosing surgery.

Causes of Knee Pain Treated
0 +
Advanced Treatment Modalities
0 +
Clinic Locations in Hyderabad
0
Close-up of the injection site for epidural spinal injections
— Key Takeaways
  • Neuropathic pain arises from nervous system damage itself — not from tissue injury — and is fundamentally different from ordinary pain
  • It is classified as central (brain/spinal cord) or peripheral (nerves outside the CNS) — each requiring very different treatment strategies
  • Major types include diabetic peripheral neuropathy, postherpetic neuralgia, trigeminal neuralgia, CRPS, phantom limb pain, CPSP, and post-chemotherapy nerve pain
  • Standard painkillers (NSAIDs, even opioids) are largely ineffective — specialist medications, interventional procedures, and physical therapies are required
  • IBAP Clinics offers the full spectrum of advanced non-surgical treatments including spinal cord stimulation, radiofrequency ablation, Botox, LASER therapy, mirror box therapy, and ketamine infusions

Imagine your home's electrical wiring suddenly starts sending false alerts — every circuit is tripping, smoke alarms are blaring at three in the morning, but there is no fire. No smoke. No actual danger. Yet the alarms will not stop. This, in essence, is what neuropathic pain does to the human body. The wiring — the nerves — has gone rogue. The signals they are sending are not reflective of any real tissue damage, but the pain is absolutely, devastatingly real.

I have sat across from patients in my clinic — software engineers from Gachibowli who can barely type, homemakers from Madeenaguda who cannot sleep past two in the morning, retired teachers whose shingles rash healed six months ago but whose chest still feels as though it is on fire. And I have watched their faces when I tell them: your pain is not imaginary. Your nervous system is damaged, and it is misfiring. And we have real tools to help you. That moment of being believed, of being understood rather than dismissed — it matters enormously. I'll return to that theme throughout this article, because empathy is not a soft science in pain medicine. It is, genuinely, part of the treatment.

7–10%
of the general population has some form of neuropathic pain
50%
of diabetic patients develop peripheral neuropathy within 25 years
30%
of shingles patients develop postherpetic neuralgia lasting months to years
60–80%
of amputees experience phantom limb pain

Understanding the Mechanism: Why Does Nerve Pain Feel So Different?

Normal "nociceptive" pain is your body's alarm system working correctly. You sprain an ankle. Tissue is damaged. Inflammation activates pain receptors. Your brain registers the signal: protect that ankle. It serves a purpose.

Neuropathic pain is entirely different. The nerve itself — the wire — has been injured, compressed, or corrupted. Now it fires spontaneously, amplifies signals, and sometimes inverts them entirely, so that a feather's touch causes agony (allodynia) or a mildly warm cup of chai feels like a burning iron rod (thermal hyperalgesia). The alarm is broken. It is not telling you about real danger anymore. It has become the problem.

The Broken Alarm Analogy

Think of your nervous system as a sophisticated CCTV and alert system in a large office building. Neuropathic pain is what happens when the sensors themselves are damaged — they start sending security alerts to the control room with no actual intruder present. Replacing the furniture (treating inflammation) does not help. You must fix or bypass the faulty sensor itself. That is precisely what interventional pain medicine does.

At the cellular level, nerve injury causes a cascade of changes: sodium channel upregulation leads to spontaneous firing; central sensitisation occurs in the spinal cord, amplifying all incoming signals; and the brain's own pain-modulating systems (the descending inhibitory pathways) become suppressed. This is why neuropathic pain is so persistent, and why it so often worsens at night when external distractions cease — your brain, without other input to process, focuses all its attention on the malfunctioning signal.

Central vs Peripheral Neuropathic Pain image matching original design
Figure 1: Central vs Peripheral Neuropathic Pain — origin, pathways, and key clinical examples.

Central Neuropathic Pain

Central Post-Stroke Pain (CPSP)

Approximately 8–11% of stroke survivors develop a particularly cruel legacy: burning, aching, shooting pain on the side of the body affected by the stroke, sometimes months after the stroke itself has resolved. It is the brain's own sensory processing circuits that have been damaged — the thalamus and spinothalamic tracts are particularly vulnerable — and the result is a pain state that is notoriously resistant to standard treatment. Many patients are told their pain is psychological, which adds insult to a very real injury. CPSP responds best to sodium channel modulators (lamotrigine), antidepressants, and — where pharmacotherapy fails — to spinal cord stimulation or motor cortex stimulation.

Spinal Cord Injury Pain

This is one of the most severe and complex pain presentations we see. When the spinal cord itself is damaged — by trauma, tumour, or inflammatory disease — the "volume dial" in the central nervous system can become permanently turned up. Patients describe below-level pain (burning in the legs despite paralysis) and at-level pain (neuropathic sensations at the injury zone) simultaneously. The disconnect between motor function and pain sensation is profoundly distressing. Here at IBAP, intrathecal drug delivery (pump systems) and neuromodulation have transformed outcomes for carefully selected patients who have not responded to oral therapy.

Key Clinical Insight

In central neuropathic pain, the spinal cord and brain have undergone a process called central sensitisation — effectively, the gain on the amplifier has been permanently increased. This is why even small peripheral stimuli trigger overwhelming pain responses, and why opioids (which target peripheral and supraspinal receptors but do not reverse central sensitisation) often provide disappointingly little relief.

Peripheral Neuropathic Pain: The Major Types

Diabetic Peripheral Neuropathy (DPN)

This is, frankly, the epidemic hiding in plain sight in India. With over 101 million diagnosed diabetics in the country — and countless more undiagnosed — diabetic peripheral neuropathy is one of the commonest pain conditions I see every week. It typically begins in the feet: a burning, pins-and-needles discomfort that is worse at night, making sleep feel like a luxury. Over time, it can affect the hands in a characteristic "glove and stocking" distribution.

I want to be direct here. The patient who has been sitting with burning feet for three years, who has been told by three different doctors to just "control your sugars," deserves better than that. Yes, glucose control is essential — and yes, early control can partially reverse nerve damage. But for established DPN, we have a growing toolkit: alpha-lipoic acid infusions (which reduce oxidative stress on nerve fibres), topical capsaicin patches, duloxetine and pregabalin combinations, and — for severe cases — spinal cord stimulation, which carries Level 1 evidence for DPN and has transformed lives in our clinic.

Postherpetic Neuralgia (PHN)

The shingles rash has healed. The blisters are gone. But the burning, stabbing, electric pain along that nerve pathway — the one that follows the stripe of the old rash — refuses to leave. This is postherpetic neuralgia. It affects 10–30% of shingles patients, with risk rising sharply after age 60. In a country like India where many adults were never vaccinated against varicella, and where the shingles vaccine remains underutilised, PHN is far commoner than it should be.

PHN is exquisitely painful. A cotton bedsheet touching the affected skin can be unbearable (allodynia at its most cruel). The first-line approach includes the gabapentinoid family and topical lidocaine patches. For those who do not respond, we offer pulsed radiofrequency neuromodulation of the affected dorsal root ganglion — a minimally invasive procedure that can provide sustained relief without any incision. Botulinum toxin (Botox) injections subcutaneously over the affected area have also emerged as a powerful second-line tool.

Trigeminal Neuralgia (TGN)

If there is a pain condition that deserves to be taken with the utmost seriousness and urgency, it is trigeminal neuralgia. Patients describe it as an electric shock to the face — triggered by eating, talking, even brushing teeth. It lasts seconds, but the intensity is such that patients have stopped eating. Stopped speaking. Stopped leaving their homes. I have met patients in my clinic who are essentially housebound because the fear of triggering a episode is itself disabling.

Carbamazepine remains the first pharmacological agent of choice. But when it fails, or when side effects (dizziness, cognitive slowing) become intolerable — as they often do in elderly patients — we have excellent interventional options: percutaneous rhizotomy, Gasserian ganglion radiofrequency ablation, and balloon compression. These are day procedures. Not surgery. The relief can be profound and long-lasting.

Complex Regional Pain Syndrome (CRPS)

CRPS is, in my experience, one of the most misunderstood and underdiagnosed conditions in pain medicine. It typically follows a relatively minor injury — a wrist fracture, a soft tissue sprain — and then, rather than resolving as expected, the pain escalates dramatically and takes on a life of its own. The affected limb becomes hot, then cold; swollen, then shrunken; shiny-skinned, then mottled. The autonomic nervous system is involved, the immune system is dysregulated, and the pain is out of all proportion to any identifiable tissue damage.

I have seen CRPS dismissed as anxiety. As exaggeration. As "attention-seeking." This is a profound failure of clinical empathy and a diagnostic error that prolongs suffering unnecessarily. CRPS is a real, biologically complex pain condition. It responds — best when caught early — to a combination of early physiotherapy, sympathetic nerve blocks (stellate ganglion or lumbar sympathetic), mirror box therapy, and, in refractory cases, spinal cord stimulation, which has the strongest evidence base in neuromodulation for CRPS I.

CRPS: The Overprotective Security System

Imagine your body's alarm system going haywire after a minor incident — a small scratch triggers full lockdown, flood lights, sirens, and emergency responders all at once. And the alarm simply will not switch off, even after the scratch has healed. That is CRPS: a catastrophic, self-perpetuating overresponse of the autonomic and immune nervous systems to what was initially a minor insult. The task of treatment is to break that vicious cycle — not dismiss the alarm as imaginary.

Phantom Limb Pain

That a patient can experience excruciating pain in a limb that no longer exists is one of the most remarkable and humbling phenomena in medicine. And yet it is completely real — neurobiologically explainable and entirely treatable. Following amputation, the brain's sensory cortex undergoes maladaptive reorganisation ("remapping"). The area of cortex that used to process signals from the missing limb begins receiving input from adjacent body regions, and the brain misinterprets these signals as coming from the phantom limb. The result: cramping, burning, or shooting pain in a hand or foot that is not there.

Mirror box therapy — a beautifully simple, low-technology intervention — places a mirror between the limbs so that the intact limb's movement creates the visual illusion of the phantom limb moving freely and painlessly. This visual feedback can rewire cortical maps and, for many patients, dramatically reduce phantom pain. It is elegant, cheap, and evidence-based. We use it as part of a broader neuromodulation and rehabilitation strategy at IBAP.

Post-Chemotherapy Peripheral Neuropathy (CIPN)

Cancer treatment saves lives. But certain chemotherapy agents — particularly platinum compounds (oxaliplatin, cisplatin), taxanes (paclitaxel), and vinca alkaloids — damage peripheral nerves as a side effect. The resulting neuropathy: numbness, burning, tingling in hands and feet, impaired balance. For some patients, it forces dose reductions or treatment cessation. And it can persist for years after chemotherapy ends.

CIPN management requires a sensitive balance: we must not compromise cancer treatment, yet the neuropathic pain significantly impairs quality of life and function. Duloxetine has the strongest evidence for CIPN symptom management. Alpha-lipoic acid and vitamin B-complex supplementation are adjuncts. For established CIPN, we use a combination of low-dose pharmacotherapy, LASER therapy (photobiomodulation has emerging evidence for nerve regeneration), and carefully supervised rehabilitation.

Post-Surgical Neuropathic Pain (Chronic Post-Surgical Pain / CPSP)

Major surgery carries an underappreciated risk that most patients are not warned about: approximately 10–50% of patients who undergo thoracotomy, mastectomy, inguinal hernia repair, or limb surgery develop chronic post-surgical pain that persists beyond three months. A significant proportion of this has a neuropathic component — nerves cut, stretched, or entrapped during surgery begin misfiring. The pain is often burning, shooting, or hypersensitive at the scar site.

Prevention is key: enhanced recovery protocols, multimodal intraoperative analgesia, and regional anaesthetic techniques all reduce the risk of CPSP. But for those who have already developed it, scar neuroma blocks, pulsed radiofrequency of peripheral nerves, topical agents, and low-dose membrane stabilisers can restore meaningful function.

Mixed Pain: When Nociceptive and Neuropathic Coexist

Real patients rarely present with neat, textbook pain types. A person with lumbar disc prolapse has both inflammatory back pain (nociceptive) from the disc and shooting leg pain from the compressed nerve (neuropathic). A patient with cancer pain may have bone pain from metastases (nociceptive), nerve entrapment pain (neuropathic), and visceral pain from organ involvement — all simultaneously. This is called mixed pain, and it requires a layered treatment approach rather than a single-agent solution. This is precisely why I am sceptical of the "one tablet fixes all" approach to chronic pain. The complexity demands complexity of response.

Pharmacotherapy for Neuropathic Pain: Evidence Overview

Drug ClassExamplesMechanismNNT*Best ForCaution
GabapentinoidsPregabalin, Gabapentinα2δ calcium channel modulation~5–7DPN, PHN, CIPNSedation, dependency risk
SNRIsDuloxetine, VenlafaxineSerotonin-noradrenaline reuptake inhibition — augments descending inhibition~5–6DPN, CIPN, mixed painGI side effects, hypertension
TCAsAmitriptyline, NortriptylineNa channel blockade + noradrenaline reuptake inhibition~3–4PHN, DPN, mixed painAnticholinergic effects, cardiac risk
Sodium Channel BlockersCarbamazepine, Lamotrigine, OxcarbazepineMembrane stabilisation — reduces ectopic firing~2 (TGN)TGN, CPSP, mixedHepatotoxicity risk, drug interactions
Topical AgentsLidocaine patches, Capsaicin 8% patch, EMLAPeripheral sodium channel block / TRPV1 desensitisation~5–8PHN, localised peripheral neuropathyApplication site reactions
NMDA AntagonistsKetamine (IV/SC), MemantineBlocks central sensitisation at NMDA receptorVariableCRPS, refractory neuropathic painPsychomimetic effects, specialist use only
OpioidsTramadol, Tapentadol, Low-dose Morphineμ-opioid + NRI (tapentadol)~4–5Third-line only; mixed pain statesDependency, tolerance, constipation; limited efficacy in pure neuropathic pain
Botulinum Toxin ABotox (injected subcutaneously / IM)Blocks vesicular release of glutamate, substance P, CGRP~4 (PHN, TGN)PHN, TGN, CRPS, chronic migraineTemporary (3–4 months), specialist procedure
SupplementsAlpha-lipoic acid, Vitamin D, B1/B6/B12 complex, NACAntioxidant; nerve fibre support; remyelination cofactors~5–6 (ALA for DPN)DPN, CIPN — as adjunctsNot stand-alone treatments; always adjunctive

*NNT = Number Needed to Treat for 50% pain reduction; lower = more effective. Values approximate based on pooled RCT data.

Why Opioids Fail in Neuropathic Pain

This is one of the most important concepts I try to communicate to patients. Opioids are powerful analgesics for nociceptive (tissue-injury) pain. But neuropathic pain is not driven by nociceptors — it is driven by misfiring nerves and central sensitisation. Opioid receptors are sparse in the pathways that perpetuate neuropathic pain. This is why a patient with severe DPN may take strong opioids and get only 20–30% relief, while the same opioid completely controls post-operative incision pain. The pain type, not the dose, is the limiting factor.

The Role of Botulinum Toxin in Neuropathic Pain

Botox for pain. I know. Many patients — and indeed some colleagues — raise an eyebrow. But the evidence here is robust and growing. Botulinum toxin A works at the peripheral nerve terminal, blocking the vesicular release of pain neurotransmitters including glutamate, substance P, and CGRP. It does not just paralyse muscles. When injected subcutaneously into an area of neuropathic pain — a PHN scar, a painful neuroma, a CRPS limb — it can substantially reduce the peripheral drive that maintains central sensitisation.

For trigeminal neuralgia, small injections into the trigger zone (forehead, cheek, chin) can provide two to four months of significant relief. For chronic migraine — technically a headache disorder but with strong neuropathic mechanisms — the PREEMPT protocol using Botox is now a NICE-approved, Level 1 evidence treatment. We use Botox injections for PHN, localised neuropathy, and carefully selected CRPS cases with great results.

Interventional & Neuromodulation Treatments

ProcedureHow It WorksBest ForDuration of EffectEvidence Level
Spinal Cord Stimulation (SCS)Electrical leads near spinal cord create paresthesia or subthreshold signals that suppress pain transmissionDPN, CRPS, failed back surgery syndrome, radiculopathyLong-term (device-based)Level I
Dorsal Root Ganglion (DRG) StimulationPrecisely targets the ganglion of a specific spinal nerve — more focal than standard SCSCRPS, focal peripheral neuropathy, post-hernia painLong-termLevel II
Radiofrequency Ablation (RFA)Thermal or pulsed energy disrupts pain-transmitting nerve fibresTrigeminal neuralgia, DRG neuropathy, facet-mediated radiculopathy6 months–2 yearsLevel II
Sympathetic Nerve BlocksInterrupts autonomic dysregulation in CRPS and vascular painCRPS, PHN acute phase, complex vascular painWeeks–months (series of blocks)Level II
Intrathecal Drug DeliveryDelivers opioid ± ziconotide directly into spinal fluid — bypasses systemic side effectsRefractory CRPS, cancer neuropathic pain, severe SCI painLong-term (device-based)Level I
Botulinum Toxin (Botox) InjectionsBlocks peripheral neurotransmitter release; modulates central sensitisationPHN, TGN, CRPS, chronic migraine3–4 months (repeatable)Level I (migraine)
Ketamine InfusionNMDA receptor antagonism reverses central sensitisationCRPS, phantom limb, refractory neuropathic painWeeks–months per courseLevel II–III
LASER Therapy (LLLT)Photobiomodulation — reduces nerve inflammation, promotes repairCIPN, peripheral neuropathy, PHNWeeks–monthsEmerging Level II
Mirror Box TherapyVisual feedback rewires cortical sensory maps; reduces maladaptive reorganisationPhantom limb pain, CRPS (Type I)Cumulative with repeated sessionsLevel II
Transcranial Magnetic Stimulation (TMS)Repetitive cortical stimulation modulates central pain processingCPSP, refractory central pain, phantom limbWeeks (repeatable courses)Level II–III

The Neuropathic Pain Reality in India: A Context That Cannot Be Ignored

I want to speak plainly here, because this is a dimension that clinical papers rarely address — but that shapes every consultation I conduct in Hyderabad.

We are living in a nation of extraordinary stress. The student preparing for NEET or JEE — sometimes 14 hours of study a day, often hunched over a phone screen in poor light, sleeping at irregular hours — is building the scaffolding for tension headaches, cervicogenic pain, and early peripheral sensitisation. I have seen teenagers in my clinic with genuine neuropathic-type head pain driven by posture, stress, and sleep deprivation. When I tell parents this, they are sometimes surprised. They had expected a "physical" cause. But stress and poor sleep are physical — they alter cortisol, disturb nerve repair cycles, and lower the pain threshold measurably.

The software engineer commuting from Kondapur to Hitech City on the Outer Ring Road is not imagining the lower back pain that shoots down their leg after forty-five minutes in traffic — aggravated by every pothole on Road No. 12, every sudden brake, every poorly timed speed breaker. That vibration is mechanical loading on an already sensitised lumbar nerve root. Carpooling does not solve sciatica. Proper diagnosis and treatment does.

The homemaker in her forties — managing the household, cooking three meals, possibly dealing with undiagnosed diabetes, and sleeping on a too-soft mattress with a pillow that is all wrong for her cervical spine — does not complain dramatically. She is stoic in the way that Indian women are trained to be. But the burning in her feet at night is real. The electric sensations in her hands are real. And they deserve the same rigorous investigation and treatment as any corporate patient.

I have also seen elderly temple-goers with postherpetic neuralgia who were told — even by well-meaning family members — that it was "vatha" (humoral imbalance) or divine punishment for past deeds. I say this with compassion, not mockery: the pain of postherpetic neuralgia is not a metaphysical failing. It is damaged dorsal root ganglia firing uncontrollably. And we can help.

The Indian Life-Stress–Pain Connection

The human nervous system evolved for intermittent stress — a predator to escape, then rest. What it did not evolve for is relentless, chronic, low-grade stress: deadlines, traffic, academic pressure, financial worry, screen fatigue — twenty-four hours a day, seven days a week. Chronic stress keeps the HPA axis activated, which raises cortisol, which suppresses immune function, disrupts sleep, and — critically — lowers the threshold at which nerve signals are perceived as painful. India's specific stressors are not just cultural context. They are neurobiological inputs into a pain equation that clinicians must take seriously.

The Importance of Being Believed

I want to end this section with something I feel strongly about. The science of neuropathic pain teaches us that the experience of being dismissed, disbelieved, or told the pain is "in your head" is not merely unkind — it is physiologically harmful. Research has demonstrated that therapeutic alliance — the quality of the doctor-patient relationship — significantly predicts outcomes in chronic pain. When patients feel understood, their central inhibitory systems function better. When they feel dismissed, their pain actually intensifies.

Empathy is not a soft skill. It is a clinical tool. And every patient who walks into IBAP Clinics deserves to be told: your pain is real, its mechanisms are understood, and we have precise, evidence-based strategies to address it.

Frequently Asked Questions

Peripheral neuropathic pain originates from damage to nerves outside the brain and spinal cord — such as in diabetic neuropathy, shingles, or carpal tunnel syndrome. Central neuropathic pain originates from disease or injury within the brain or spinal cord itself — such as after a stroke (CPSP), spinal cord injury, or in multiple sclerosis. Both produce similar symptoms (burning, shooting pain, allodynia) but differ in their underlying mechanisms, their response to different treatments, and the interventions available. Central pain is generally harder to treat and requires more complex strategies.
NSAIDs and paracetamol work by reducing tissue inflammation and blocking peripheral pain receptor activation — mechanisms that are not the primary driver in neuropathic pain. Opioids do have some efficacy but are classified as third-line agents in most neuropathic pain guidelines, because the pathways that perpetuate neuropathic pain (central sensitisation, ectopic nerve firing, NMDA receptor activation) are not efficiently targeted by opioid receptors. The correct first-line agents are gabapentinoids, SNRIs, or tricyclic antidepressants — which specifically modify neural signalling rather than inflammatory pathways.
Strict glucose control — ideally brought to near-normal early in the course of diabetes — can slow the progression of DPN and, in early stages, partially restore nerve function. However, once significant axonal degeneration has occurred, the structural damage is largely irreversible. This does not mean nothing can be done: symptom control with targeted pharmacotherapy, alpha-lipoic acid infusions, and where appropriate, spinal cord stimulation, can meaningfully reduce pain and restore sleep, mobility, and quality of life. The message is: control your sugars urgently — and do not wait for pain to become severe before seeking specialist assessment.
Complex Regional Pain Syndrome (CRPS) is a chronic neuropathic pain condition, usually affecting a limb, that typically follows a relatively minor injury — a fracture, sprain, or even a surgical procedure. The key features (Budapest Criteria) include: pain disproportionate to the original injury, allodynia or hyperalgesia, changes in skin colour or temperature, swelling or sweating abnormalities, and movement restriction. CRPS is diagnosed clinically — there is no single blood test or scan that confirms it. If you have had an injury and the pain has continued or worsened beyond the expected healing time, with any of the above features, please seek specialist assessment urgently. Early treatment is dramatically more effective.
Botulinum toxin A (Botox) has a well-established and expanding role in pain medicine that is entirely distinct from its cosmetic applications. When injected subcutaneously or intramuscularly near affected nerves, it blocks the release of pain neurotransmitters including substance P, glutamate, and CGRP. This reduces peripheral sensitisation and over time helps to reduce central sensitisation as well. Evidence supports its use in chronic migraine (Level I, NICE-approved), postherpetic neuralgia, trigeminal neuralgia trigger zones, and CRPS. The effects last approximately 3–4 months and the procedure is safely repeatable.
Mirror box therapy was developed by neuroscientist V.S. Ramachandran as a way to use visual feedback to "trick" the brain into updating its body map following amputation. A mirror is placed vertically between the limbs so that when the intact limb moves, its reflection appears to be the missing limb moving. This visual feedback activates the sensory cortex in a way that can reduce the maladaptive reorganisation responsible for phantom pain. Multiple studies have shown significant pain reduction with regular practice (typically 20–30 minutes daily). At IBAP, we integrate mirror therapy into a broader rehabilitation plan — it is most effective when combined with graded motor imagery and, where appropriate, spinal cord stimulation.
IBAP Clinics offers a comprehensive, evidence-based range of non-surgical neuropathic pain treatments tailored to each patient's specific pain type and severity. These include: spinal cord stimulation (SCS) and DRG stimulation; radiofrequency ablation (thermal and pulsed); sympathetic nerve blocks and Gasserian ganglion procedures; intrathecal drug delivery pump implantation; botulinum toxin injections; ketamine infusion therapy; LASER photobiomodulation; mirror box and graded motor imagery therapy; precision-guided pharmacotherapy optimisation; and multidisciplinary rehabilitation coordination. Every treatment plan at IBAP starts with a thorough diagnostic assessment to identify the precise pain generator — because treating the right target makes all the difference.

Living With Neuropathic Pain? We Can Help.

Advanced, non-surgical neuropathic pain treatment in Hyderabad. Led by Dr Vijay Bhaskar Bandikatla — FRCA, FFPMRCA, Cambridge Advanced Pain Training.

🏥 Banjara Hills Clinic

2nd Floor, 284/A, Road No. 12
Above IDFC First Bank
Near Omega Hospitals, MLA Colony
Hyderabad – 500 034

🏥 Madeenaguda Clinic

Sy No. 2, 4th Floor, Plot No. 200
Beside South India Shopping Mall
Opp. Fortune Heights, Mythri Nagar
Madeenaguda, Hyderabad – 500 049

References & Further Reading

  1. Finnerup NB, et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 2015;14(2):162–173.
  2. Treede RD, et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology. 2008;70(18):1630–1635.
  3. Attal N, et al. EFNS guidelines on pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol. 2010;17(9):1113-e88.
  4. de Vos CC, et al. Spinal cord stimulation in patients with painful diabetic neuropathy: a multicentre randomized clinical trial. Pain. 2014;155(11):2426–2431.
  5. Cruccu G, et al. Trigeminal neuralgia: new classification and diagnostic grading for practice and research. Neurology. 2016;87(2):220–228.
  6. Harden NR, et al. Validation of proposed diagnostic criteria (the "Budapest Criteria") for Complex Regional Pain Syndrome. Pain. 2010;150(2):268–274.
  7. Grosen K, et al. Persistent post-surgical pain: evidence for spinal cord stimulation. Pain. 2021;162(Suppl 1):S95–S102.
  8. Zanette G, et al. Subcutaneous botulinum toxin type A reduces capsaicin-induced trigeminal pain and neurogenic vasodilation in humans. Neurosci Lett. 2007;418(1):13–17.
  9. Ramachandran VS, Rogers-Ramachandran D. Synaesthesia in phantom limbs induced with mirrors. Proc Biol Sci. 1996;263(1369):377–386.
  10. Hershman DL, et al. Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers. J Clin Oncol. 2014;32(18):1941–1967.
  11. Smith AG, et al. Effect of alpha-lipoic acid on diabetic neuropathy: an evidence-based review. J Diabetes Investig. 2020;11(3):527–535.
  12. Deer TR, et al. The Neurostimulation Appropriateness Consensus Committee (NACC) safety guidelines for the reduction of severe neurological injury. Neuromodulation. 2017;20(1):15–30.
⚠ Medical Disclaimer

This article is intended for general educational purposes only and does not constitute medical advice, diagnosis, or a treatment recommendation. Neuropathic pain is a complex condition requiring individual clinical assessment. The treatments described carry specific indications, contraindications, and risks that must be discussed with a qualified pain medicine specialist. Please consult Dr Vijay Bhaskar Bandikatla or your treating physician before making any decisions regarding your pain management. IBAP Clinics | Vijay Advanced Pain Clinics Pvt. Ltd. | Hyderabad, India.

Happy Patients - Live Testimonials

Meenakshi, 75 years - Relived From Knew Pain

Mrs. Naga Sathyavathi relieved from Back Pain & Shoulder Pain

Mr. Bhaskar Reddy inspiring recovery from L1 Spine Issue.

Raghav Reddy recovered from Pain to Relief

Mr. Chakrapani recovered from Severe Joint and Neck Pain

Happy Patients - Google Reviews

Dr. Vijay Bhaskar Bandikatla

Founder IBAP Clinics, Pain Physician MBBS · DA · FRCA (London) · FFPMRCA (Pain Medicine) · CCT (UK) · Advanced Pain Training (Cambridge) · Fellowship in Neuromodulation & Advanced Pain (London) · DDSMed (Sports Medicine, Pune ISST— ISPA, Chicago) MBA (Hospital Management)

Dr Vijay Bhaskar Bandikatla

Founder & Interventional Pain Specialist — IBAP Clinics, Hyderabad
MBBS · DA · FRCA (London) · FFPMRCA (Pain Medicine, UK) · MBA (Hospital Management)
CCT (Anaesthesia & Pain Medicine, UK) · Advanced Pain Training (Cambridge University Hospitals)
DDSMed Sports Medicine (Chicago) · Fellowship in Neuromodulation & Advanced Pain (London)

Dr Vijay brings over 15 years of postgraduate training across the United Kingdom’s most prestigious institutions — including the Royal College of Anaesthetists, Cambridge University Hospitals, and a dedicated neuromodulation fellowship in London — to his practice in Hyderabad. He is one of very few clinicians in India trained to the level of FFPMRCA — the Faculty of Pain Medicine of the Royal College of Anaesthetists — the highest qualification in pain medicine available in the UK.

His specialist expertise spans the full spectrum of knee pain management: from precision PRP and BMAC injections to cooled radiofrequency genicular nerve ablation, intrathecal drug delivery, and spinal cord stimulation for refractory pain states. He manages cases ranging from the weekend cricketer’s torn meniscus to the elderly cardiac patient with end-stage OA who has been told there are no further options.

Epidural Spinal Injections

Epidural Spinal Injections

Epidural injections involve the injection of medication, usually a combination of a local anesthetic and a corticosteroid, into the epidural space around the spinal cord. This procedure is commonly used to alleviate pain and inflammation associated with conditions such as herniated discs, spinal stenosis, and sciatica. The local anaesthetic provides immediate pain relief by numbing nerves, while the corticosteroid helps reduce inflammation for longer-term effects. The epidural space is the outermost part of the spinal canal, located just outside the protective membrane called the dura mater.The injection is typically administered by a qualified healthcare professional, such as an anesthesiologist or pain management specialist. The goal of an epidural spinal injection is to reduce inflammation and alleviate pain caused by various conditions affecting the spine and surrounding tissues
Close-up of the injection site for epidural spinal injections

Some common reasons for undergoing this procedure include:

  • Herniated Disc: When the soft inner material of a spinal disc protrudes through the tough outer layer, it can irritate nearby nerves, causing pain.
  • Spinal Stenosis: This is a narrowing of the spinal canal, which can put pressure on the spinal cord and nerves, leading to pain and discomfort.
  • Degenerative Disc Disease: As the discs between the vertebrae age and break down, they can contribute to pain and inflammation.
  • Sciatica: Inflammation or compression of the sciatic nerve, which runs from the lower back down the back of each leg, can cause pain, numbness, and tingling.
  • Spinal Arthritis: Inflammatory conditions affecting the spine, such as ankylosing spondylitis or osteoarthritis, can lead to pain and stiffness.

Our goal is to help the patient regain their quality of life

In our pain clinic, we provide pain relief so you can regain your identity.

Chat with us

Book An Appointment

Choose Branch